A Study of LY2605541 Versus Insulin Glargine on Blood Sugar
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
LY2605541 is an investigational drug being developed for the treatment of diabetes mellitus.
This study is designed to understand how the body handles the investigational drug, what
effect this investigational drug has on the body, and how much should be given. This study
will also measure how much of the investigational drug gets into the blood stream and how
long it takes the body to get rid of it. The study has 2 parts: Part A will be conducted in
healthy participants. Part B will be conducted in participants with type 1 diabetes mellitus
(T1DM). This study will take approximately 10-14 days spread over 6-20 weeks, not including
screening. Screening will be performed within 30 days of the start of the study.